Confluence Life Sciences, Inc.
12Patents
12Active
12Granted
48Portfolio score
Filing activity: Dec 6, 2011 → Jan 25, 2016
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9695200B2 | Heterocyclic ITK inhibitors for treating inflammation and cancer | Chemistry; Metallurgy | 14 | Active |
| US9115089B2 | Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds | Chemistry; Metallurgy | 8 | Active |
| US9636333B2 | Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds | Chemistry; Metallurgy | 6 | Active |
| US9056110B2 | Substituted pyrimidinone-phenyl-pyrimidinyl compounds | Chemistry; Metallurgy | 4 | Active |
| US9365547B2 | Substituted pyridinone-pyridinyl compounds | Chemistry; Metallurgy | 4 | Active |
| US9365546B2 | Substituted pyridinone-pyridinyl compounds | Chemistry; Metallurgy | 4 | Active |
| US9359300B2 | Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds | Chemistry; Metallurgy | 4 | Active |
| US9505765B2 | 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment | Human Necessities | 2 | Active |
| US9499551B2 | Substituted pyrrolo[2,3-b]pyridines for treating cancer or inflammatory diseases | Chemistry; Metallurgy | 2 | Active |
| US9145393B2 | Arylpyridinone ITK inhibitors for treating inflammation and cancer | Chemistry; Metallurgy | 2 | Active |
| US8563558B2 | Substituted pyridine urea compounds | Chemistry; Metallurgy | 0 | Active |
| US8507499B2 | Substituted indole/indazole-pyrimidinyl compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.